OREANDA-NEWS. Pfizer Inc. (NYSE:PFE) addresses some challenging questions often posed by shareholders and the public in its latest integrated annual review for 2014. In a series of video Q&As, Pfizer colleagues respond to questions such as: “Why do people say medicines are so expensive?” and “Why is it so difficult to find a cure for cancer?”

The 2014 integrated report also highlights a number of partnerships focused on collaborative research and development, how Pfizer is tackling the rise in non-communicable diseases, and access to medicines in low- and middle-income countries. Healthy and active aging also figures prominently in the annual review, reflecting the rapid shift in global demographics.

Ian C. Read, Pfizer chairman and chief executive officer, writes in his annual letter to shareholders included in the annual review that Pfizer “is on a multi-year journey, and during 2014 we achieved a number of important milestones despite a slow-growth global economy and the losses of exclusivity and co-promotion rights to some of our major medicines. We are concentrating our efforts on seeking to profitably grow our business and expanding our sources of revenue, strengthening our core businesses, and bringing forth new therapies that significantly improve peoples' lives.”